AXLA — Axcella Health Share News
0.000.00%
Last trade - 00:00Axcella surges on U.S. application for human study of long COVID fatigue treatment
Brief: Axcella Announces Regulatory Path To Registration For Long Covid Fatigue treatment
Brief: Axcella Health Inc Receives Nasdaq Notice For Non-Compliance With Minimum Bid Price Requirement
U.S. STOCKS ON THE MOVE-ANI Pharmaceuticals, Steelcase, Otonomy
U.S. RESEARCH ROUNDUP- Adobe, Costar, Verisign
Axcella slips on plans to restructure, discontinue NASH drug trial
Brief: Axcella Announces Program Reprioritization And Corporate Restructuring
Axcella Health Inc reports results for the quarter ended in September - Earnings Summary
Brief: Axcella Reports Third Quarter Financial Results And Provides Business Update
Axcella Health Inc expected to post a loss of 38 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-BeiGene, Avient, Reata
U.S. STOCKS ON THE MOVE-Netflix, BeiGene, Norfolk
U.S. STOCKS ON THE MOVE-Howard Hughes, Rocket Lab, Relmada Therapeutics
Wedbush cuts PT on Axcella Therapeutics, remains bullish on pipeline potential
Brief: Axcella Therapeutics Announces $34.2 Million Registered Direct Offering Of Common Stock Priced At The Market Appoints Two New Board Members
Brief: Axcella Health Files For Offering Of Up To 20.85 Million Shares Of Common Stock - SEC Filing
U.S. STOCKS ON THE MOVE-EV stocks, Sarepta, Senti Biosciences
U.S. STOCKS ON THE MOVE-Peloton, Rivian, Proterra, Gamida
U.S. STOCKS ON THE MOVE-Axsome Therapeutics, Miners, Bed Bath & Beyond